D. Elshan Nakath G. Ralalage

D. Elshan Nakath G. Ralalage has a diverse work experience in the field of medicinal chemistry. D. Elshan started their career as a Researcher at the University of Colombo, where they conducted research on the design, synthesis, and biological evaluation of a vesicular monoamine transporter inhibitor. D. Elshan then worked as an Assistant Manager at Pharm House Pharmacy, where they managed various aspects of the business and served as an assistant pharmacist.

Afterwards, they joined Sanofi as an Intern in Medicinal Chemistry, gaining experience in the pharmaceutical industry and participating in a drug discovery project. D. Elshan then worked at the University of Arizona as a Researcher in Medicinal Chemistry, targeting specific cell surface receptors and mentoring undergraduate students.

D. Elshan furthered their career at UCLA as a Scientist in Medicinal Chemistry, focusing on the development of novel drugs for metastatic castration-resistant prostate cancer under the guidance of renowned professors. D. Elshan continued their research work at Calibr at Scripps Research, first as an Investigator and then as a Principal Investigator and later as Associate Director - Medicinal Chemistry. In these roles, they led multiple research areas, managed internal teams and collaborations, contributed to synthesis efforts and project milestone decisions, and progressed a major discovery project.

Throughout their career, D. Elshan Nakath G. Ralalage has demonstrated expertise in medicinal chemistry, project management, and team leadership, and has made significant contributions to various research projects in the field.

D. Elshan Nakath G. Ralalage began their education journey in 2004 at the University of Colombo, where they pursued a Bachelor of Science degree in Chemistry, which they completed in 2008. Following their undergraduate studies, they joined the University of Arizona in 2009 for their doctoral research. They successfully obtained a Doctor of Philosophy (Ph.D.) degree in Chemistry in 2014. Subsequently, in 2015, they continued their academic pursuit as a Postdoctoral Scholar at UCLA, specializing in Medicinal and Pharmaceutical Chemistry.